Webinars

Prevention and treatment
CKD case study from the cardiometabolic institute

Prevention and treatment CKD case study from the cardiometabolic institute

Summary

Chronic kidney disease is a common and often silent condition - up to one in ten adults could be affected, yet only one-third of these will have had a diagnosis1,2. Early detection can slow disease progression or even prevent it altogether - which is why testing in at-risk groups is so important.

In this webinar, Prof. Stephan Jacob raises awareness of the interconnected relationship between renal and cardiovascular risks, emphasizing the crucial role of early detection in slowing disease progression and reducing the risk of developing additional health complications.

Our international speakers discuss the role of rapid diagnostics in disease prevention with point-of-care testing such as an Albumin Creatinine Ratio (ACR) assay, enabling healthcare providers to detect, and treat, kidney disease in minutes.

Learn more about current guidelines and kidney disease prevention and management.

Learning Objectives

  • Importance of regular testing for early detection and monitoring in high-risk patients
  • Importance of ACR testing beside the determination of eGFR
  • Latest guidance on disease prevention and management
  • Case studies

References

  1. Sundström J, Bodegard J, Bollmann A et al. CaReMe CKD study: Prevalence, outcomes, and cost of CKD in a contemporary population of 2.4 million patients from11 countries. The Lancet Regional Health Europe 2022;00:100438
  2. The international Society of Nephrology (ISN). Chronic Kidney Disease: https://www.worldkidneyday.org/events/chronic-kidney-disease/

Presenter Biography

Dr. Stephan Jacob
Germany

Dr. Jacob is an Endocrinologist, Diabetologist, Nutrition expert and clinical hyperextension specialist in private practice.

Who Should Watch

Healthcare Professionals, Physicians, Clinicians, Nurses, POC Coordinators